drugset / Trial / NCT04073472

Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's

NCT04073472 ↗

Phase 1 Withdrawn The Cleveland Clinic
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and feasibility of using allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat people with an ileal pouch anal anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch.

Timeline

Start
2021-06-01
Primary completion
2022-06-01
Completion
2023-06-01

Outcome

Outcome not reported

Stopped: “This clinical trial was entered in error. Please refer to the correct entry of this study using the following link: https://clinicaltrials.gov/ct2/show/NCT04519684”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal Stem Cells (MSCs) Cell therapy 7.5e+07 cells Other